pemafibrate
Kowa Pharmaceuticals
['cardio']
#prominent trial in patients w/ #t2dm, mild/mod hypertriglyceridemia, &amp; low hdl + ldl, no difference in incidence of cardiovascular events among those treated with #pemafibrate vs placebo
#lbct #aha22 
Cardiologist @BIDMCHealth @HarvardMed | Assistant Professor @HarvardMed | Section Head, Health Policy & Equity Research @SmithBIDMC |Associate PD @BIDMCVfellows